Trials / Conditions / Lung Cancer Non-Small Cell Cancer (NSCLC)
Lung Cancer Non-Small Cell Cancer (NSCLC)
8 registered clinical trials studyying Lung Cancer Non-Small Cell Cancer (NSCLC) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC NCT07405190 | Massachusetts General Hospital | Phase 2 |
| Recruiting | Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC NCT06810609 | University Hospital, Bonn | Phase 2 |
| Recruiting | Cross-sectorial Rehabilitation of Patients with Lung Cancer NCT06705465 | Camilla Balle | N/A |
| Completed | Real-World Immuno-Radiotherapy for Advanced NSCLC NCT06747026 | Fengming Kong | — |
| Terminated | Pulmonary Interstitial Lymphography in Early Stage Lung Cancer NCT01188486 | Stanford University | N/A |
| Terminated | Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors NCT01071434 | Stanford University | — |
| Terminated | Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors NCT01137162 | Stanford University | — |
| Available | Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors NCT06872489 | Second Life Therapeutics | — |